Vanessa Belozeroff

Vanessa Graham Belozeroff currently serves as the AVP of Portfolio, Program Leadership & Management at Organon, overseeing strategic leadership for the company's pipeline in women's health. Prior to this role, Vanessa held the position of Executive Director for Portfolio Management & Business Excellence at Amgen, where responsibilities included managing Biosimilars programs and leading operations for the Biosimilars business unit, along with being the Therapeutic area head for Hematology-Oncology and Bone portfolio. Vanessa's extensive experience also includes leadership roles in clinical operations at Essential CRO, global project management at Aventis, global program management at Abbott Laboratories, and medical program administration at Johnson and Johnson. Vanessa began her career as a Sr. Chemist/Clinical Research Associate at US Bioscience and worked as a Research Scientist at the University of Idaho Analytical Sciences Laboratory. Vanessa holds a BS in Molecular Biology/Biochemistry from the University of Idaho and an MBA from Eastern University.